A rare brain tumor found with a DNA test after a leukemia history
Original title: Primary Intracranial CIC-Rearranged Sarcoma With Prior History of B-Cell ALL: A Case Report.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report on one patient who was already treated, not a test of a new treatment.
The short version
Doctors used a special DNA test to name a rare brain tumor in one young patient when the usual lab tests could not.
What was studied. This is a report about one patient. The patient had been treated before for B-cell acute lymphoblastic leukemia, a type of blood cancer. They came to the hospital with seizures and weakness in the left arm.
What they found. Brain scans showed a mass in the right front part of the brain. Surgeons removed it. The first lab tests could not say exactly what kind of tumor it was. Doctors then tested chemical tags on the tumor's DNA and ran the results through a brain tumor classifier tool. That gave the answer: CIC-rearranged sarcoma. A second lab test confirmed it. The patient got chemotherapy using the ICE protocol along with focused radiation. The tumor came back in the same place 14 months after diagnosis.
What this means, and what it doesn't
What it could mean: For patients with a hard to name brain tumor, a DNA-based test may help doctors reach the right diagnosis faster. The authors say the tool made diagnosing this rare tumor easier. The report also says clearly that there is still no treatment known to work well for this tumor type.
What it doesn't mean: This is a report about a single patient. It is not a study, and one patient cannot tell us what will happen for anyone else. It does not show a new treatment. It is not a cure, and it is not a promise that this tumor can be controlled. The tumor in this report came back after treatment.
Source: PubMed, August 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.